All four patients with early-stage rectal cancer who still had circulating tumor DNA (ctDNA) in their blood after ...
The investigational drug rinatabart sesutecan (Rina-S) shrank tumors in 45.9% of patients with platinum-resistant ovarian ...
Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...
On Sept. 30, 2026, the FDA withdrew the accelerated approval of Zepzelca (lurbinectedin) for adults with metastatic small ...
The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...
The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...
Liver cancer treatment has changed a lot in five years, and how it changed tells you a lot about where it’s going. Most of ...
The hardest part of living with metastatic triple-negative breast cancer, a cancer that has spread to other parts of the body ...
In a phase 2 study, Ojemda (tovorafenib) led to responses in 43% of adults with melanoma or other solid tumors that carried rare RAF gene changes. Ojemda (tovorafenib) shrank tumors in 10 of 23 adults ...
Lyrfigtu (lirafugratinib), a once-daily pill, is for previously treated cholangiocarcinoma with an FGFR2 fusion or ...
California Gov. Gavin Newsom signed Assembly Bill 1682, which requires certain health plans to cover scalp cooling for people receiving chemotherapy. Starting J ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results